MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression

Genes Chromosomes and Cancer

Volumn 54, Issue 3, 2015, Pages 129-141

  Amirkhah, Raheleh ^a   Schmitz, Ulf ^b   Linnebacher, Michael ^b   Wolkenhauer, Olaf ^b,c   Farazmand, Ali ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; GENE CONTROL; GENE EXPRESSION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN NUCLEIC ACID INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR GROWTH; COLORECTAL TUMOR; DISEASE COURSE; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

APOPTOSIS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER;

EID: 84921519778     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22231     Document Type: Review

References (112)

1. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D. 2010. miRNAs in colon and rectal cancer: A consensus for their true clinical value. Clin Chim Acta 411:1181-1186.
2. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafa R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA. 2012. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142:886-896 e889.
3. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128-2136.
4. Aslam MI, Patel M, Singh B, Jameson JS, Pringle JH. 2012. MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application. J Transl Med 10:128.
5. Bader AG. 2012. miR-34-A microRNA replacement therapy is headed to the clinic. Front Genet 3:120.
6. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J. 2009. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15:2281-2290.
7. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zollner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA. 2012. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 33:732-739.
8. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
9. Boardman LA. 2009. Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 1:36.
10. Bonfrate L, Altomare DF, Di Lena M, Travaglio E, Rotelli MT, De Luca A, Portincasa P. 2013. MicroRNA in colorectal cancer: New perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis 22:311-320.
11. Cai C, Ashktorab H, Pang X, Zhao Y, Sha W, Liu Y, Gu X. 2012. MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5. PLoS One 7:e29750.
12. Chandramouli A, Onyeagucha BC, Mercado-Pimentel ME, Stankova L, Shahin NA, LaFleur BJ, Heimark RL, Bhattacharyya AK, Nelson MA. 2012. MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers. Cancer Biol Ther 13:175-183.
13. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, Zhang J, Zhang CY. 2009. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28:1385-1392.
14. Chen HY, Lin YM, Chung HC, Lang YD, Lin CJ, Huang J, Wang WC, Lin FM, Chen Z, Huang HD, Shyy JY, Liang JT, Chen RH. 2012. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 72:3631-3641.
15. Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH. 2013. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis 34:803-811.
16. Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, Maitra A, Mendell JT. 2014. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell 157:1104-1116.
17. Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Orntoft TF, Andersen CL. 2013. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer 133:67-78.
18. de Krijger I, Mekenkamp LJ, Punt CJ, Nagtegaal ID. 2011. MicroRNAs in colorectal cancer metastasis. J Pathol 224:438-447.
19. Doberstein K, Steinmeyer N, Hartmetz AK, Eberhardt W, Mittelbronn M, Harter PN, Juengel E, Blaheta R, Pfeilschifter J, Gutwein P. 2013. MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia 15:218-230.
20. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
21. Fang JY, Richardson BC. 2005. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6:322-327.
22. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
23. Feng B, Dong TT, Wang LL, Zhou HM, Zhao HC, Dong F, Zheng MH. 2012. Colorectal cancer migration and invasion initiated by microRNA-106a. PLoS One 7:e43452.
24. Fu J, Tang W, Du P, Wang G, Chen W, Li J, Zhu Y, Gao J, Cui L. 2012. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Syst Biol 6:68.
25. Garzon R, Marcucci G, Croce CM. 2010. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9:775-789.
26. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A, Lund AH. 2010. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 5:e8836.
27. Gregersen LH, Jacobsen A, Frankel LB, Wen J, Krogh A, Lund AH. 2012. MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells. BMC Cancer 12:232.
28. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K. 2008. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47:939-946.
29. Guo H, Chen Y, Hu X, Qian G, Ge S, Zhang J. 2013a. The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells. Mol Cancer 12:77.
30. Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY, Yang RH, Feng Y, Wang FH, Tseng HY, Thorne RF, Jin L, Zhang XD. 2013b. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 32:1910-1920.
31. Han HB, Gu J, Zuo HJ, Chen ZG, Zhao W, Li M, Ji DB, Lu YY, Zhang ZQ. 2012. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J Pathol 226:544-555.
32. He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J. 2012. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 18:1491-1498.
33. Hu M, Xia M, Chen X, Lin Z, Xu Y, Ma Y, Su L. 2010. MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells. Dig Dis Sci 55:2365-2372.
34. Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L, Sheng W, He X, Du X. 2011. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 71:2582-2589.
35. Hurst DR, Edmonds MD, Welch DR. 2009. Metastamir: The field of metastasis-regulatory microRNA is spreading. Cancer Res 69:7495-7498.
36. Ibrahim AF, Weirauch U, Thomas M, Grunweller A, Hartmann RK, Aigner A. 2011. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71:5214-5224.
37. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, Wakabayashi G, Mori M, Mimori K. 2012. Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33:2391-2397.
38. Jansson MD, Lund AH. 2012. MicroRNA and cancer. Mol Oncol 6:590-610.
39. Kent OA, McCall MN, Cornish TC, Halushka MK. 2014. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res 42:7528-7538.
40. Kim S, Choi M, Cho KH. 2009. Identifying the target mRNAs of microRNAs in colorectal cancer. Comput Biol Chem 33:94-99.
41. Kozomara A, Griffiths-Jones S. 2011. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152-D157.
42. Le XF, Merchant O, Bast RC, Calin GA. 2010. The roles of microRNAs in the cancer invasion-metastasis cascade. Cancer Microenviron 3:137-147.
43. Li J, Du L, Yang Y, Wang C, Liu H, Wang L, Zhang X, Li W, Zheng G, Dong Z. 2013a. MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett 329:84-90.
44. Li Q, Zou C, Han Z, Xiao H, Wei H, Wang W, Zhang L, Zhang X, Tang Q, Zhang C, Tao J, Wang X, Gao X. 2013b. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett 335:168-174.
45. Li Y, Zhu X, Xu W, Wang D, Yan J. 2013c. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42. Biochem Biophys Res Commun 431:560-565.
46. Li XJ, Ren ZJ, Tang JH. 2014. MicroRNA-34a: A potential therapeutic target in human cancer. Cell Death Dis 5:e1327.
47. Liao WT, Li TT, Wang ZG, Wang SY, He MR, Ye YP, Qi L, Cui YM, Wu P, Jiao HL, Zhang C, Xie YJ, Wang JX, Ding YQ. 2013. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res 19:4662-4672.
48. Liu L, Chen L, Xu Y, Li R, Du X. 2010. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 400:236-240.
49. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F. 2011a. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 301:151-160.
50. Liu X, Zhang Z, Sun L, Chai N, Tang S, Jin J, Hu H, Nie Y, Wang X, Wu K, Jin H, Fan D. 2011b. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 32:1798-1805.
51. Liu K, Zhao H, Yao H, Lei S, Lei Z, Li T, Qi H. 2013a. MicroRNA-124 regulates the proliferation of colorectal cancer cells by targeting iASPP. Biomed Res Int 2013:867537.
52. Liu L, Nie J, Chen L, Dong G, Du X, Wu X, Tang Y, Han W. 2013b. The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One 8:e55532.
53. Luo H, Zou J, Dong Z, Zeng Q, Wu D, Liu L. 2012. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Biochem J 442:311-321.
54. Ma Y, Zhang P, Wang F, Zhang H, Yang Y, Shi C, Xia Y, Peng J, Liu W, Yang Z, Qin H. 2012. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun 3:1291.
55. Ma Q, Wang X, Li Z, Li B, Ma F, Peng L, Zhang Y, Xu A, Jiang B. 2013. microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway. Oncol Rep 29:1652-1658.
56. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ. 2003. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882-891.
57. Motrescu ER, Blaise S, Etique N, Messaddeq N, Chenard MP, Stoll I, Tomasetto C, Rio MC. 2008. Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene 27:6347-6355.
58. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA, Agami R. 2008. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68:5795-5802.
59. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P. 1997. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389:631-635.
60. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, Rocken C, Ebert MP, Kwok TT, Sung JJ. 2009. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101:699-706.
61. Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y, Du X, Han W. 2012. microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis 33:220-225.
62. Nugent M, Miller N, Kerin MJ. 2011. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 37:649-654.
63. Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, Runci D, Forte S, De Maria R, Ricci-Vitiani L. 2013. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 32:4806-4813.
64. Paulmurugan R. 2013. MicroRNAs-A new generation molecular targets for treating cellular diseases. Theranostics 3:927-929.
65. Pickup M, Novitskiy S, Moses HL. 2013. The roles of TGFbeta in the tumour microenvironment. Nat Rev Cancer 13:788-799.
66. Qin J, Luo M. 2014. MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK. FEBS Lett 588:99-104.
67. Qin S, Zhu Y, Ai F, Li Y, Bai B, Yao W, Dong L. 2014. MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. Neoplasma 61:27-34.
68. Ruan K, Fang X, Ouyang G. 2009. MicroRNAs: Novel regulators in the hallmarks of human cancer. Cancer Lett 285:116-126.
69. Ryan KM, Ernst MK, Rice NR, Vousden KH. 2000. Role of NF-kappaB in p53-mediated programmed cell death. Nature 404:892-897.
70. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY. 2009. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106:3207-3212.
71. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA. 2006. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9:435-443.
72. Schetter AJ, Okayama H, Harris CC. 2012. The role of microRNAs in colorectal cancer. Cancer J 18:244-252.
73. Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q, Liu J. 2012. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 84:320-330.
74. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R. 2007. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282:32582-32590.
75. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J. 2009. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28:4065-4074.
76. Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V. 2009. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 315:1439-1447.
77. Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, Yang AG, Zhang R. 2012. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin. Biochem Biophys Res Commun 420:787-792.
78. Sun K, Deng HJ, Lei ST, Dong JQ, Li GX. 2013. miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol 19:2197-2207.
79. Thomas M, Lange-Grunweller K, Weirauch U, Gutsch D, Aigner A, Grunweller A, Hartmann RK. 2012. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 31:918-928.
80. To KK. 2013. MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy. J Biomed Sci 20:99.
81. Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM, Xiao SD, Ran ZH. 2011. MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett 585:3560-3568.
82. Tsang WP, Kwok TT. 2009. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 30:953-959.
83. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT. 2010. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 31:350-358.
84. Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H. 2011. Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res 71:4628-4639.
85. Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, Nuovo GJ, Fishel R, Croce CM. 2010. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA 107:21098-21103.
86. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241-250.
87. Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko RJ, Jr., Lazo JS, Wang Z, Zhang L, Yu J. 2009. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 69:8157-8165.
88. Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W. 2011. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 32:1033-1042.
89. Wang F, Zhang P, Ma Y, Yang J, Moyer MP, Shi C, Peng J, Qin H. 2012a. NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. Cancer Lett 314:223-231.
90. Wang Z, Zhang X, Yang Z, Du H, Wu Z, Gong J, Yan J, Zheng Q. 2012b. MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. Biochem Biophys Res Commun 427:444-449.
91. Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L. 2013. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer 49:3924-3935.
92. Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG. 2010. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70:5923-5930.
93. Wu SP, Theodorescu D, Kerbel RS, Willson JK, Mulder KM, Humphrey LE, Brattain MG. 1992. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 116:187-196.
94. Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF. 2012. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 33:519-528.
95. Wu CW, Dong YJ, Liang QY, He XQ, Ng SS, Chan FK, Sung JJ, Yu J. 2013a. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. PLoS One 8:e57036.
96. Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y. 2013b. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 12:30.
97. Xiong B, Cheng Y, Ma L, Zhang C. 2013. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol 42:219-228.
98. Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, Lai L, Jiang BH. 2012. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40:761-774.
99. Xu RS, Wu XD, Zhang SQ, Li CF, Yang L, Li DD, Zhang BG, Zhang Y, Jin JP, Zhang B. 2013. The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. Int J Oncol 42:676-682.
100. Yamada N, Noguchi S, Mori T, Naoe T, Maruo K, Akao Y. 2013. Tumor-suppressive microRNA-145 targets catenin delta-1 to regulate Wnt/beta-catenin signaling in human colon cancer cells. Cancer Lett 335:332-342.
101. Yamakuchi M, Ferlito M, Lowenstein CJ. 2008. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105:13421-13426.
102. Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH, Liu LZ. 2013. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim Biophys Acta 1829:239-247.
103. Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH, Majumdar AP. 2012. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis 33:68-76.
104. Yu XY, Zhang Z, Liu J, Zhan B, Kong CZ. 2013. MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B. Onco Targets Ther 6:349-354.
105. Zhai H, Ju J. 2011. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet 2.
106. Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng H, Lai M. 2011. MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ 18:1702-1710.
107. Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q, Ma F, Jiang B. 2012. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer 11:23.
108. Zhang GJ, Zhou H, Xiao HX, Li Y, Zhou T. 2013a. Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer. Cancer Cell Int 13:104.
109. Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y, Wang K, Wan J. 2013b. MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One 8:e70300.
110. Zhang G, Zhou H, Xiao H, Liu Z, Tian H, Zhou T. 2014. MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN. Dig Dis Sci 59:98-107.
111. Zhong M, Bian Z, Wu Z. 2013. miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem 31:209-218.
112. Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng L, Chen F, Peng F, Li X. 2013. MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1. PLoS One 8:e63142.